Skip to content
Research/Peptide Blends Stacks/Ipamorelin + CJC-1295 + IGF-1 LR3

Ipamorelin + CJC-1295 + IGF-1 LR3

Triple GH/growth factor stack for maximizing anabolic signaling through GH axis activation plus direct IGF-1 augmentation. Maximum GH, IGF-1, muscle growth, performance, recovery.

Intelligence Profile

Science

Mechanism of Action

Based on available evidence, this three-compound combination targets the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) pathways through complementary mechanisms, though clinical data supporting their combined use is extremely limited.

Ipamorelin functions as a growth hormone-releasing peptide (GHRP) that selectively binds to and activates the ghrelin receptor (growth hormone secretagogue receptor) in the pituitary gland. This stimulates the release of endogenous growth hormone without significantly affecting cortisol or prolactin levels, unlike some other GHRPs.

CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors on somatotroph cells in the anterior pituitary. The modified version (CJC-1295 DAC) includes a drug affinity complex that extends its half-life, allowing for sustained stimulation of growth hormone release over several days.

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 with modifications that extend its half-life and reduce its binding to IGF-binding proteins. It directly activates IGF-1 receptors in target tissues, promoting protein synthesis, muscle growth, and cellular repair processes.

The theoretical rationale combines upstream GH stimulation (ipamorelin and CJC-1295) with direct downstream IGF-1 receptor activation (IGF-1 LR3), potentially creating synergistic effects on the GH-IGF1 axis.

Important limitations: The evidence base for this specific combination is very thin. One review discusses the emerging use of such peptide combinations in performance enhancement contexts, but robust clinical trials examining safety, efficacy, or optimal dosing protocols for this three-compound regimen are notably absent from the medical literature. The molecular mechanisms described are based on individual compound actions rather than validated combination effects.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult healthcare professionals before considering any peptide therapy.